Apex Medical Corp.

TWSE:4106.TW

25.25 (TWD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Revenue 2,647.1222,663.7232,374.0552,004.0252,036.2322,105.7482,089.2771,990.2752,015.8942,263.3572,016.9711,845.7711,748.5181,661.2161,577.269
Cost of Revenue 1,508.8051,596.9351,387.1031,156.3941,182.4151,228.8771,182.7541,112.0941,114.7291,216.8221,165.9741,104.2511,114.8831,025.534979.348
Gross Profit 1,138.3171,066.788986.952847.631853.817876.871906.523878.181901.1651,046.535850.997741.52633.635635.682597.921
Gross Profit Ratio 0.430.40.4160.4230.4190.4160.4340.4410.4470.4620.4220.4020.3620.3830.379
Reseach & Development Expenses 165.762154.283150.746167.827138.194132.163138.934102.93194.50488.55779.88383.88882.50677.23369.965
General & Administrative Expenses 399.368346.897362.973307.525307.265317.452331.286355.998350.047474.486284.152158.785124.507103.035108.097
Selling & Marketing Expenses 379.127379.485369.226275.461273.896290.413284.726259.953246.861258.697304.597259.468211.174230.866178.159
SG&A 778.495726.382732.199582.986581.161607.865616.012615.951596.908733.183588.749418.253335.681333.901286.256
Other Expenses -944.09822.52438.56519.0319.42227.34923.55523.04618.60130.08223.86325.24415.596.36911.542
Operating Expenses 944.098880.665882.945750.813719.355740.028754.946718.882691.412821.74668.632502.141418.187411.134356.221
Operating Income 194.219211.903145.435132.006152.121136.843151.577159.299209.753224.795182.365239.379215.448224.548241.7
Operating Income Ratio 0.0730.080.0610.0660.0750.0650.0730.080.1040.0990.090.130.1230.1350.153
Total Other Income Expenses Net 15.634-11.366-7.354-7.162-23.69513.4280.1892.83114.87927.17821.19225.08354.098-2.62916.072
Income Before Tax 209.853200.537138.081124.844128.426150.271151.766162.13224.632251.973203.557264.462269.546221.919257.772
Income Before Tax Ratio 0.0790.0750.0580.0620.0630.0710.0730.0810.1110.1110.1010.1430.1540.1340.163
Income Tax Expense 56.84138.42334.5719.46739.62240.95434.08339.44350.69953.86757.32859.35635.64842.47848.689
Net Income 152.172161.404102.247104.58887.921108.413118.263122.504168.745178.414133.466196.22232.561180.681212.185
Net Income Ratio 0.0570.0610.0430.0520.0430.0510.0570.0620.0840.0790.0660.1060.1330.1090.135
EPS 1.511.61.011.040.871.171.421.472.022.141.62.252.792.172.55
EPS Diluted 1.51.591.011.030.871.131.341.452.012.131.592.232.772.162.54
EBITDA 317.641305.214238.981211.28232.966221.903236.933260.19330.651364.403311.105329.097313.385273.209323.264
EBITDA Ratio 0.120.1150.1010.1050.1140.1050.1130.1310.1640.1610.1540.1780.1790.1640.205